Neoleukin Therapeutics (NLTX) Q2 2023 Earnings

Aug 10Confirmed
Nov 2022
Q4 2022
Q1 2023
Q2 2023
-0.3
-0.21
-0.13
-0.04

Details

Expected EPS
-0.04
Actual EPS
-0.04
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Neoleukin Therapeutics⁩ (⁦NLTX⁩) has reported earnings of ⁦-0.04⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts